A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

Clinical trial NCT03309319 · UNKNOWN

Trial details

NCT number: NCT03309319
Sponsor: Zhaoyun Zhang
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Pituitary Tumor

Start date: 2016-10-16
Primary completion: 2018-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.